State Street’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

State Street’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-230,248	Closed	-$12.7M	–	5020
2022 Q2	$12.7M	Buy	+230,248	New	+$12.1M	﹤0.01%	2560

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

State Street's SRRA Position: Q3 2022 in Review

State Street sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 230,248 shares — an estimated $12.7M sold.

State Street first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $12.7M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

State Street reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
State Street sold 230,248 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $12.7M.
State Street first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
State Street's Sierra Oncology, Inc. Common Stock position peaked at $12.7M in Q2 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.